Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2010
08/19/2010US20100210516 Growth Factor Binding Molecules
08/19/2010US20100210514 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210513 RNAi Inhibition of Alpha-ENaC Expression
08/19/2010US20100210512 Thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome
08/19/2010US20100210476 Pyrrolo[2,3-b]Pyridine Derivatives Active as Kinase Inhibitors and Pharmaceutical Compositions Comprising Them
08/19/2010US20100209532 Targeted oxygen delivery via intravenous or intra-arterial infusion of oxygenated polymerized hemoglobin solutions
08/19/2010US20100209529 Pharmacologic-functioning water and usage of the same
08/19/2010US20100209516 Triggered Drug Release Via Physiologically Responsive Polymers
08/19/2010US20100209513 Pharmaceutical composition containing micronized particles of naphthoquinone-based compound
08/19/2010US20100209510 Extended Release Formulation and Method of Treating Adrenergic Dysregulation
08/19/2010US20100209506 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
08/19/2010US20100209488 Protein kinase modulating compounds and methods for making and using them
08/19/2010US20100209480 Galenical formulations of organic compounds
08/19/2010US20100209476 Coating comprising a terpolymer comprising caprolactone and glycolide
08/19/2010US20100209471 Medical devices having polymeric nanoporous coatings for controlled therapeutic agent delivery and a nonpolymeric macroporous protective layer
08/19/2010US20100209467 Tdf-related compounds and analogs thereof, analogs and bioactive fragments
08/19/2010US20100209445 Mutant double cyclized receptor peptides inhibiting beta1-adrenoceptor antibodies
08/19/2010US20100209442 Deglycosylated and desialidated long pentraxin ptx3
08/19/2010US20100209441 Drug for suppressing pathogen occurring in vivo
08/19/2010US20100209433 Methods for the diagnosis and for the treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists
08/19/2010US20100209408 Remodeling of Tissues and Organs
08/19/2010US20100209403 Adherent cells from adipose or placenta tissues and use thereof in therapy
08/19/2010US20100209401 Use of SDF-1 to Improve Ischemic Myocardial Function
08/19/2010US20100209383 Use of g-csf for treating ischemia
08/19/2010US20100209359 Medicated chewing gum
08/19/2010US20100209345 Fluorinated Ligands for Targeting Peripheral Benzodiazepine Receptors
08/19/2010DE102009009030A1 Use of juice of the apple berry (Aronia melanocarpa) for: improving the physical performance, preferably during prolonged constant stress (preferably running and cycling); and as an agent for high blood pressure and for healing sunburn
08/19/2010DE102009008186A1 Feste orale pharmazeutische Zusammensetzung umfassend einen hydrophoben Wirkstoff A solid oral pharmaceutical composition comprising a hydrophobic drug
08/19/2010DE102009008185A1 Zusammensetzung umfassend einen hydrophoben Wirkstoff sowie ein Phospholipid A composition comprising a hydrophobic drug and a phospholipid
08/19/2010CA2752211A1 Fibronectin type iii domain based scaffold compositions, methods and uses
08/18/2010EP2218736A1 Implant coated with multi-domain amphipathic helical peptides and methods of their use
08/18/2010EP2218716A1 Method for amplifying hematopoietic stem cells using heterocyclic compound
08/18/2010EP2218459A1 Sustained release composition containing sdf-1
08/18/2010EP2218451A1 Use of FTS for treating malignant disorders
08/18/2010EP2217280A1 Diagnostic and therapeutic methods and compositions for cardiovascular disease
08/18/2010EP2217242A1 Methods of use
08/18/2010EP2041104B1 Cinnamoyl-piperazine derivatives and their use as par- i antagonists
08/18/2010EP1979355B1 Spiro imidazole derivatives as ppar modulators
08/18/2010EP1951692B1 Oxazole and thiazole ppar modulator
08/18/2010EP1940828B1 Heterocyclic aspartyl protease inhibitors
08/18/2010EP1578423B1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists
08/18/2010EP1411910B1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum
08/18/2010EP1400510B1 Cyclic diamine compounds having fused-ring groups
08/18/2010EP1320526B1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
08/18/2010EP0956865B2 MEDICINES COMPRISING Rho KINASE INHIBITOR
08/18/2010CN1837202B Flavonols with blood-fat-lowering effect
08/18/2010CN1823803B Erigeron breviscapus injection preparation and its preparation method
08/18/2010CN1704121B Anti-angiogenic compositions and methods of use
08/18/2010CN101809027A selective inhibitors of neurotensin degrading enzymes
08/18/2010CN101809005A Fused bicyclic compound
08/18/2010CN101809002A morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
08/18/2010CN101808649A Micro-RNAs that control myosin expression and myofiber identity
08/18/2010CN101805784A Single nucleotide polymorphism of human WNK4 genes and application thereof
08/18/2010CN101805750A Construction and application of farnesyl pyrophosphoric acid synthetase RNA (Ribonucleic Acid) interference recombinant lentivirus vector
08/18/2010CN101805688A Mulberry health-care wine and preparation method thereof
08/18/2010CN101805410A Technological method for comprehensively producing pueraria flavonid, puerarin and arrowroot starch
08/18/2010CN101805391A Preparation method of sodium tanshinone IIA for injection
08/18/2010CN101805340A Beta-chain simulative and correlation method thereof
08/18/2010CN101805332A Preparation method and application of puerarin derivatives
08/18/2010CN101805289A Omega-crystal form, preparation method and medicine composite of ivabradine hydrochloride
08/18/2010CN101805285A Nicotinic acid-contained curcumin ester derivative and preparation method and application thereof
08/18/2010CN101804187A Chinese traditional medicine composition for treating chronic ischemic cerebrovascular disease
08/18/2010CN101804184A Traditional Chinese medicine composition for treating chest distress and preparation method thereof
08/18/2010CN101804183A Medicine for treating coronary heart disease
08/18/2010CN101804167A Chinese drug for calming endopathic wind and reducing blood pressure and preparation method thereof
08/18/2010CN101804161A Traditional Chinese medicine for treating high blood pressure
08/18/2010CN101804152A Yixinshu tablet
08/18/2010CN101804151A Method for preparing Yixinshu tablets
08/18/2010CN101804150A Traditional Chinese medicine composite used for treating left ventricular diastolic dysfunction
08/18/2010CN101804141A Chinese medicine compound for preventing and curing hypertension, hyperlipidemia, hyperglycemia and complications thereof
08/18/2010CN101804125A Longan health wine
08/18/2010CN101804111A Traditional Chinese medicine for treating high blood pressure and preparation method thereof
08/18/2010CN101804110A Traditional Chinese medicine preparation for purifying blood
08/18/2010CN101804106A Medicine cushion and medicine bag for treating diseases of whole body
08/18/2010CN101804086A Preparation method of fermented red ginseng product
08/18/2010CN101804076A Traditional Chinese medicine preparation used for treating cerebral thrombosis combined with atrial fibrillation
08/18/2010CN101804055A Compound medicinal preparation
08/18/2010CN101804054A Application, preparation and preparation method of synthetic palmatine
08/18/2010CN101804046A Application of myricetin for Janus kinase inhibitor medicines
08/18/2010CN101804033A Atenolol non-pH-dependent sustained release pellets and preparation method thereof
08/18/2010CN101804029A Atorvastatin liposome and preparation method thereof, and medicine composition containing atorvastatin
08/18/2010CN101803970A Chair with haemorrhoids therapeutic equipment and medicine
08/18/2010CN101601656B Edaravone liposome injection and new application thereof
08/18/2010CN101601654B Hydrochloric acid Fasudil liposome injection and new application thereof
08/18/2010CN101416944B Sodium ferulic acid nano micelle preparation and preparation method thereof
08/18/2010CN101278913B Novel polyethylene glycol-phospholipid entrapped prostaglandin E1 micelle preparation
08/18/2010CN101244209B Medicament for preventing or treating cardiovascular and cerebrovascular diseases
08/18/2010CN101234102B Peperphentonamine hydrochloride freeze-dried injection and preparation and application thereof
08/18/2010CN101195647B Hydroxyl carthamus tinctorius yellow colour A, preparation method and application thereof
08/17/2010US7777057 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7777018 CDR-grafted anti-tissue factor antibodies and methods of use thereof
08/17/2010US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776898 Opioid receptor active compounds
08/17/2010US7776895 Inhalation devices for delivering phenethanolamine derivatives for the treatment of respiratory diseases
08/17/2010US7776879 anticholinergic agents such as Butylthiophen-2-ylmethylcarbamic acid 1-azabicyclo[2.2.2]oct-3-(R)yl ester, having a high affinity for muscarinic M3 receptors, useful for treating respiratory system, urogenital, gastrointestinal and cardiovascular disorders
08/17/2010US7776854 1,3-benzothiazol-2-yl(2-{[4-(morpholin-4-ylmethyl)benzyl]oxy}pyrimidin-4-yl)-acetonitrile; (or benzimidazole or benzoxazole 2-acetonitrile derivatives); systemic sclerosis, CREST, sine scleroderma, cirrhosis, heart failure; inhibitors of JNK (c-Jun N-terminal Kinases)
08/17/2010US7776853 Dietetics therapy; lipase inhibitor
08/17/2010US7776829 lupus; for patients who are refractory or intractable to corticosteroid treatment, and treatment with cyclophosphamide, azathioprine, mycophenolate mofetil, anti-thymocyte-globin, methotrexate and immunoglobulin
1 ... 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 ... 1595